Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jan-Feb;10(1):22-7.
doi: 10.1016/j.jcct.2015.12.005. Epub 2015 Dec 15.

Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry

Affiliations
Multicenter Study

Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry

Chaitu Cheruvu et al. J Cardiovasc Comput Tomogr. 2016 Jan-Feb.

Abstract

Background: Coronary computed tomography angiography (coronary CTA) can prognosticate outcomes in patients without modifiable risk factors over medium term follow-up. This ability was driven by major adverse cardiovascular events (MACE).

Objective: Determine if coronary CTA could discriminate risk of mortality with longer term follow-up. In addition we sought to determine the long-term relationship to MACE.

Methods: From 12 centers, 1884 patients undergoing coronary CTA without prior coronary artery disease (CAD) or any modifiable CAD risk factors were identified. The presence of CAD was classified as none (0% stenosis), mild (1% to 49% stenosis) and obstructive (≥50% stenosis severity). The primary endpoint was all-cause mortality and the secondary endpoint was MACE. MACE was defined as the combination of death, nonfatal myocardial infarction, unstable angina, and late target vessel revascularization (>90 days).

Results: Mean age was 55.6 ± 14.5 years. At mean 5.6 ± 1.3 years follow-up, 145(7.7%) deaths occurred. All-cause mortality demonstrated a dose-response relationship to the severity and number of coronary vessels exhibiting CAD. Increased mortality was observed for >1 segment non-obstructive CAD (hazard ratio [HR]:1.73; 95% confidence interval [CI]: 1.07-2.79; p = 0.025), obstructive 1&2 vessel CAD (HR: 1.70; 95% CI: 1.08-2.71; p = 0.023) and 3-vessel or left main CAD (HR: 2.87; 95% CI: 1.57-5.23; p = 0.001). Both obstructive CAD (HR: 6.63; 95% CI: 3.91-11.26; p < 0.001) and non-obstructive CAD (HR: 2.20; 95% CI: 1.31-3.67; p = 0.003) predicted MACE with increased hazard associated with increasing CAD severity; 5.60% in no CAD, 13.24% in non-obstructive and 36.28% in obstructive CAD, p < 0.001 for trend.

Conclusions: In individuals being assessed for CAD with no modifiable risk factors, all-cause mortality in the long term (>5 years) was predicted by the presence of more than 1 segment of non-obstructive plaque, obstructive 1- or 2-vessel CAD and 3 vessel/left main CAD. Any CAD, whether non-obstructive or obstructive, predicted MACE over the same time period.

Keywords: All-cause mortality; Coronary artery disease; Coronary computed tomographic angiography; Major adverse cardiovascular events.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests

None declared.

Figures

Figure 1
Figure 1
Unadjusted Kaplan–Meier curve for mortality-free survival on the basis of the presence of no CAD, non-obstructive CAD, 1&2 vessel obstructive CAD and 3 vessel obstructive & left main CAD for individuals without modifiable CAD risk factors (p values based on log-rank tests).
Figure 2
Figure 2
Unadjusted Kaplan–Meier curve for MACE-free survival on the basis of the presence of no CAD, non-obstructive CAD, 1&2 vessel obstructive CAD and 3 vessel obstructive & left main CAD for individuals without modifiable CAD risk factors (p values based on log-rank tests).

Similar articles

Cited by

References

    1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American heart association. Circulation. 2011;123:933–944. - PubMed
    1. Wilson PW, D’Agostino R, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. - PubMed
    1. Versteylen MO, Joosen IA, Shaw LJ, Narula J, Hofstra L. Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol. 2011;18:904–911. - PMC - PubMed
    1. Leipsic J, Taylor CM, Grunau G, Heilbron BG, Mancini GB, Achenbach S, et al. Cardiovascular risk among stable individuals suspected of having coronary artery disease with no modifiable risk factors: results from an international multicenter study of 5262 patients. Radiology. 2013;267:718–726. - PubMed
    1. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah MH, Berman DS, et al. Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN for clinical outcomes: an InteRnational Multicenter) Regist J Cardiovasc Comput Tomogr. 2011;5:84–92. - PubMed

Publication types